Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Chris Masterjohn

๐Ÿ‘ค Speaker
1255 total appearances

Appearances Over Time

Podcast Appearances

The Joe Rogan Experience
#2420 - Chris Masterjohn

And you don't just want to look at what do seed oils do to you when you're 25, because you might not be seeing the capacity for the increased vulnerability of tissue damage.

The Joe Rogan Experience
#2420 - Chris Masterjohn

Another thing is the trials have to be long enough, both because it takes time to see the process of tissue damage play out, and also because we know from long trials of seed oils that

The Joe Rogan Experience
#2420 - Chris Masterjohn

that short trials are useless.

The Joe Rogan Experience
#2420 - Chris Masterjohn

A lot of the people who are talking the loudest in defense of seed oils are looking at trials that last seven weeks long or 12 weeks long, and they're ignoring trials that were done in the 50s, 60s, and 70s that were five to eight years long.

The Joe Rogan Experience
#2420 - Chris Masterjohn

by all means, analyze the shorter trials, but do it in the light of what we know from the longer trials.

The Joe Rogan Experience
#2420 - Chris Masterjohn

And the most important of the longer trials was the LA Veterans Administration Hospital Study,

The Joe Rogan Experience
#2420 - Chris Masterjohn

And this was the primary paper on it was published in 1969.

The Joe Rogan Experience
#2420 - Chris Masterjohn

So it takes us back in history.

The Joe Rogan Experience
#2420 - Chris Masterjohn

But there was a period between World War II and 1970s where there was a lot of motivation in the research community to do these grand randomized controlled trials of nutrition.

The Joe Rogan Experience
#2420 - Chris Masterjohn

We don't have that anymore.

The Joe Rogan Experience
#2420 - Chris Masterjohn

And I think it's because...

The Joe Rogan Experience
#2420 - Chris Masterjohn

Scientists love to, in their collective imagination, to say that what they're doing is they're just carrying forth a linear path of addressing knowledge gaps left from the previous literature and just making a linear progress in science.

The Joe Rogan Experience
#2420 - Chris Masterjohn

But they're really not because the incentive structure is to publish a large number of papers in high-impact journals on a yearly basis as your university reviews get done.

The Joe Rogan Experience
#2420 - Chris Masterjohn

And then there's other incentives, too, because you have to get grants with preliminary data.

The Joe Rogan Experience
#2420 - Chris Masterjohn

So you have shorter studies that you then say, well, I'm going to do a longer study now, and it keeps the grant cycle going.

The Joe Rogan Experience
#2420 - Chris Masterjohn

And then the people who write the grants want to see things getting published out of those papers.

The Joe Rogan Experience
#2420 - Chris Masterjohn

So for you to be like, I'm going to do a 12-year randomized controlled trial of seed oils, it's going to be hard to get the people, you know, get all those box checked.

The Joe Rogan Experience
#2420 - Chris Masterjohn

Like you might not be publishing a paper for a while.

The Joe Rogan Experience
#2420 - Chris Masterjohn

So what the LA Veterans Administration hospital study showed was that